Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting4
Active Not Recruiting1
Withdrawn1
Unknown1

Clinical Trials (7)

Showing 7 of 7 trials
NCT00830557Recruiting

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

NCT07413029RecruitingPrimary

French National Cohort of Patients With PRSS1 Mutations

NCT02206360Active Not Recruiting

Pancreatic Cancer Early Detection Program

NCT02078245UnknownPrimary

Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.

NCT04743479Recruiting

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

NCT04095195Recruiting

Registry of Subjects at Risk of Pancreatic Cancer

NCT02309632Not ApplicableWithdrawn

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Showing all 7 trials

Research Network

Activity Timeline